Search

Your search keyword '"Carboplatin -- Intellectual property"' showing total 345 results
Start Over Descriptor "Carboplatin -- Intellectual property"
345 results on '"Carboplatin -- Intellectual property"'

51. Patent Application Titled 'Combination Of Micheliolide Derivatives Or Nanoparticles With Ionizing Radiation And Checkpoint Inhibitors For Cancer Therapy' Published Online (USPTO 20200261403)

Subjects
Cancer, Women's health, Ionizing radiation, Vincristine -- Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Radiotherapy, Ofatumumab -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2020

52. Researchers Submit Patent Application, 'Suppression And Inhibition Of CDC25B With Safranal-Based Formulations', for Approval (USPTO 20200253890)

Subjects
Liver cancer, Vincristine -- Intellectual property, Women's health, Carboplatin -- Intellectual property, Sorafenib -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 SEP 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor Amin, [...]

Published
2020

53. 'Hsp70 Based Combination Therapy' in Patent Application Approval Process (USPTO 20200237860)

Subjects
Physical fitness, B cells, Nivolumab, Communicable diseases, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Heat shock proteins, Health
Abstract

2020 AUG 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventor MULTHOFF, Gabriele (Munich, DE), filed on [...]

Published
2020

54. Immutep granted patent for eftilagimod alpha in chemo-immunotherapy combination

Subjects
Chemotherapy, Carboplatin -- Intellectual property, Immunotherapy, Business, News, opinion and commentary
Abstract

Immutep announced the grant of a new patent entitled 'Combined Preparations for the Treatment of Cancer' by the United States Patent Office. This United States patent follows the grant of [...]

Published
2020

56. 'Melatonin For Preventing And Treating Radiation Cystitis' in Patent Application Approval Process (USPTO 20200197367)

Subjects
Physical fitness, Ionizing radiation, Conjugated estrogens -- Intellectual property, Phenazopyridine, Carboplatin -- Intellectual property, Cystitis -- Prevention, Health
Abstract

2020 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors Lindblad, Lasse (lsgarde, DK); Uttenthal, Lars [...]

Published
2020

57. Researchers Submit Patent Application, 'Combination Therapy', for Approval (USPTO 20200197430)

Subjects
Gemcitabine -- Intellectual property, Pancreatic cancer -- Development and progression, Women's health, Carboplatin -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor Griffith, [...]

Published
2020

58. Patent Issued for Antibodies Having Specificity To Nectin-4 And Uses (USPTO 10,675,357)

Subjects
Vincristine -- Intellectual property, Women's health, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Antibodies, Biological products -- Intellectual property, Proteins, Health, Women's issues/gender studies
Abstract

2020 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Lopez, Marc (Marseilles, FR); Olive, Daniel (Marseilles, FR), filed [...]

Published
2020

59. Researchers Submit Patent Application, 'Stable Pharmaceutical Formulations Of Pemetrexed', for Approval (USPTO 20200155556)

Subjects
Cipla Ltd. -- Intellectual property, Tromethamine -- Intellectual property, Physical fitness, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Pembrolizumab, Pharmaceutical industry -- Intellectual property, Pemetrexed -- Intellectual property, EDTA -- Intellectual property, Chemotherapy, Obesity, Cancer treatment, Antineoplastic agents, Editors, Health
Abstract

2020 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2020

60. Patent Issued for Anti-Mesothelin Immunoconjugates And Uses Therefor (USPTO 10,647,779)

Subjects
Cidofovir -- Intellectual property, Physical fitness, Vincristine -- Intellectual property, Bevacizumab -- Intellectual property, Carboplatin -- Intellectual property, Sorafenib -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Fluoxymesterone -- Intellectual property, Obesity, Anopheles, Cancer, Editors, Health
Abstract

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Kahnert, Antje (Dusseldorf, DE); Unterschemmann, Kerstin (Dusseldorf, [...]

Published
2020

61. Patent Issued for SMAC Mimetic (USPTO 10,596,220)

Subjects
Apoptosis, Women's health, Carboplatin -- Intellectual property, Proteins, Editors, Health, Women's issues/gender studies
Abstract

2020 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Medivir Ab (Huddinge, Sweden) has been issued patent number 10,596,220, according to news reporting [...]

Published
2020

62. 'IgE Antibodies For The Inhibition Of Tumor Metastasis' in Patent Application Approval Process (USPTO 20200087413)

Subjects
Bevacizumab -- Intellectual property, Women's health, Carboplatin -- Intellectual property, Biological products -- Intellectual property, Cancer metastasis, Immunoglobulin E, Allergy, Antibodies, Health, Tumors, Editors, Women, Health, Women's issues/gender studies
Abstract

2020 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Mollick, Joseph A. (Palo Alto, CA); Teo, Pearline [...]

Published
2020

63. 'Targeting Dna-Pkcs And B7-H1 To Treat Cancer' in Patent Application Approval Process (USPTO 20200061077)

Subjects
Cancer genetics, Cancer, Women's health, Chemotherapy, DNA, Carboplatin -- Intellectual property, Cancer treatment, Antineoplastic agents, Medical personnel training, Immunotherapy, Editors, Women, Health, Women's issues/gender studies
Abstract

2020 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventor Dong, Haidong (Rochester, MN), filed on November 12, [...]

Published
2020

64. Patent Application Titled 'Ruthenium Complexes For Treating Cancer Which Comprises Cancer Stem Cells' Published Online (USPTO 20200054647)

Subjects
Cancer treatment, Ruthenium -- Intellectual property, Cancer, Carboplatin -- Intellectual property, Stem cells, Stem cell research, Antineoplastic agents -- Intellectual property, Clofarabine, Platinum group compounds, Vincristine, Pemetrexed, Editors, Health
Abstract

2020 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2020

65. Patent Issued for Targeting DNA-PKcs And B7-H1 To Treat Cancer (USPTO 10,517,875)

Subjects
Cancer genetics, Women's health, Chemotherapy, DNA, Carboplatin -- Intellectual property, Cancer treatment, Antineoplastic agents, Medical personnel training, Immunotherapy, Editors, Cancer patients, Health, Women's issues/gender studies
Abstract

2020 JAN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2020

66. Patent Application Titled 'Treatment Of Pancreatic Cancer' Published Online (USPTO 20190380994)

Subjects
Cancer treatment, Physical fitness, Pancreatic cancer, Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Panitumumab, Obesity, Vemurafenib, Vincristine, Pemetrexed, Cetuximab, Editors, Sunitinib, Health
Abstract

2020 JAN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2020

67. Patent Issued for Combined Anticancer Drug Sensitivity-Determining Marker (USPTO 10,481,160)

Subjects
Physical fitness, Bevacizumab -- Intellectual property, Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Panitumumab, Obesity, Dasatinib, Cancer, Cetuximab, Editors, Health
Abstract

2019 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Tanigawara, Yusuke (Shinjuku-ku, JP); Nishimuta, Akito (Shinjuku-ku, [...]

Published
2019

68. Patent Application Titled 'Pharmaceutical Composition For Preventing Or Treating Cancer' Published Online (USPTO 20190343854)

Subjects
Cancer treatment, Aminolevulinic acid -- Intellectual property, Cancer, Women's health, Cancer prevention, Bevacizumab -- Intellectual property, Artemisinin -- Intellectual property, Carboplatin -- Intellectual property, Nilotinib, Antineoplastic agents -- Intellectual property, Neratinib -- Intellectual property, Decitabine, Lapatinib, Pemetrexed, Health, Vandetanib, Temsirolimus, Cetuximab, Dasatinib, Vincristine, Axitinib, Editors, Sunitinib, Health, Women's issues/gender studies
Abstract

2019 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

69. Researchers Submit Patent Application, 'Combination Of Micheliolide Derivatives Or Nanoparticles With Ionizing Radiation And Checkpoint Inhibitors For Cancer Therapy', for Approval (USPTO 20190314324)

Subjects
Cancer, Women's health, Ionizing radiation, Vincristine -- Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Radiotherapy, Ofatumumab -- Intellectual property, Cancer treatment, Radiation (Physics), Antineoplastic agents, Health, Women, Nanoparticles, Editors, Health, Women's issues/gender studies
Abstract

2019 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Lin, [...]

Published
2019

70. Patent Application Titled 'Hydrogels With Liposomes For Controlled Release Of Drugs' Published Online (USPTO 20190307691)

Subjects
Drug delivery systems -- Intellectual property, Physical fitness, Bevacizumab -- Intellectual property, Patient compliance, Carboplatin -- Intellectual property, Ophthalmology, Obesity, Editors, Health
Abstract

2019 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2019

71. OncoQuest Receives 'Notice of Allowance' for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients

Subjects
Oregovomab, Women's health, Cancer prevention, Chemotherapy, Carboplatin -- Intellectual property, Cancer patients, Biological products -- Intellectual property, Ovarian cancer, Patent law, Medical supplies, Cancer treatment, Trademarks, Antibodies, Immunotherapy, Editors, Health, Women's issues/gender studies
Abstract

2019 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- OncoQuest Inc., a privately held, cancer immunotherapy company announced that a Notice of Allowance [...]

Published
2019

72. Patent Application Titled 'A Highly Stable, Protease-Resistant E. Coli Asparaginase' Published Online (USPTO 20190270978)

Subjects
Hydrolysis, Asparagine, Physical fitness, Pamidronate -- Intellectual property, Proteases -- Intellectual property, Aspartate -- Intellectual property, Carboplatin -- Intellectual property, Fludrocortisone, Fluoxymesterone -- Intellectual property, Antineoplastic agents -- Intellectual property, Suramin -- Intellectual property, Escherichia coli, Amino acids, Sorafenib, Pemetrexed, Temsirolimus, Pomalidomide, Carfilzomib, Obesity, Everolimus, Asparaginase, BCG, Vincristine, Editors, Sunitinib, Health
Abstract

2019 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2019

73. Researchers Submit Patent Application, 'A Nanocomplex', for Approval (USPTO 20190262271)

Subjects
Cancer treatment, Physical fitness, Hyaluronidase -- Intellectual property, Patient compliance, Carboplatin -- Intellectual property, Obesity, Technology, Metals (Materials), Editors, Health
Abstract

2019 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

75. Patent Issued for Liposomal Cisplatin Compositions For Cancer Therapy (USPTO 10,383,823)

Subjects
Cancer treatment, Physical fitness, Cancer, Carboplatin -- Intellectual property, Cisplatin -- Intellectual property, DNA, Cancer cells, Obesity, Antineoplastic agents, RNA, Editors, RNA synthesis, Health
Abstract

2019 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2019

77. Researchers Submit Patent Application, 'Combination Therapies Using HDAC Inhibitors', for Approval (USPTO 20190216755)

Subjects
Vincristine -- Intellectual property, Women's health, Patents, Carboplatin -- Intellectual property, CAT scans, Editors, Patent/copyright issue, Health, Women's issues/gender studies
Abstract

2019 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Lichenstein, [...]

Published
2019

78. 'Veliparib In Combination With Carboplatin For The Treatment Of Triple Negative Breast Cancer' in Patent Application Approval Process (USPTO 20190216783)

Subjects
Women's health, Carboplatin -- Intellectual property, Breast cancer, Carcinoma, Antineoplastic agents, Epithelial tumors, Tumors, Editors, Women, Health, Women's issues/gender studies
Abstract

2019 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventor Gordon, Gary (Highland Park, IL), filed on March [...]

Published
2019

81. 'Gelling Compositions For Treating Malignant Tumours And/Or Preventing Tumour Recurrence' in Patent Application Approval Process (USPTO 20190192430)

Subjects
Carboplatin -- Intellectual property, Women -- Health aspects, Tumors, Diseases -- Relapse, Health, Women's issues/gender studies
Abstract

2019 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Mignet, Nathalie (Clamart, FR); Boudy, Vincent Pierre-Marie (Paris, [...]

Published
2019

82. Immutep granted patent covering eftilagimod alpha by European Patent Office

Subjects
Chemotherapy, Carboplatin -- Intellectual property, Cancer treatment, Antineoplastic agents, Immunotherapy, Business, News, opinion and commentary
Abstract

Immutep announced the grant of a new patent by the European Patent Office. The new patent protects Immutep's intellectual property relating to combined therapeutic preparations comprising its active immunotherapy candidate [...]

Published
2019

83. Patent Application Titled 'Peptides And Nanoparticle Formulations Thereof' Published Online (USPTO 20190119340)

Subjects
Peptides, Carboplatin -- Intellectual property, Amino acids -- Intellectual property, Pertuzumab, Women's health, Cancer, Health, Editors, Health, Women's issues/gender studies
Abstract

2019 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

84. Researchers Submit Patent Application, 'Compounds For Use In The Treatment Of Cancer', for Approval (USPTO 20190105289)

Subjects
Cancer, Carboplatin -- Intellectual property, Cancer research, Cancer treatment, Olaparib, Women's health, Women, Diphtheria, Health, Editors, Health, Women's issues/gender studies
Abstract

2019 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Lehtio, [...]

Published
2019

85. Researchers Submit Patent Application, 'Treatment Of Cancer By Systemic Administration Of Dbait Molecules', for Approval (USPTO 20190091254)

Subjects
Cancer, Carboplatin -- Intellectual property, Cancer research, Cancer treatment, Women's health, Women, Breast cancer, Anopheles, Editors, Health, Women's issues/gender studies
Abstract

2019 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Dutreix, [...]

Published
2019

86. Patent Issued for Use Of Eribulin And Poly (ADP Ribose) Polymerase (PARP) Inhibitors As Combination Therapy For The Treatment Of Cancer (USPTO 10,238,630)

Subjects
Cancer, Carboplatin -- Intellectual property, Cancer treatment, Monosaccharides, Olaparib, Women's health, Antineoplastic agents -- Intellectual property, Eribulin mesylate, Health, Editors, Health, Women's issues/gender studies
Abstract

2019 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Cox, David (Oakland, NJ); Kremer, Alton (Weston, CT); McGonigle, [...]

Published
2019

87. 'Combination Therapy Using A Liv1-Adc And A Chemotherapeutic' in Patent Application Approval Process (USPTO 20190085091)

Subjects
Seagen Inc. -- Intellectual property, Carboplatin -- Intellectual property, Biological products industry -- Intellectual property, Women -- Health aspects, Biotechnology industry -- Intellectual property, Pertuzumab, Chemotherapy, Cancer -- Chemotherapy, Health, Women's issues/gender studies
Abstract

2019 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Sussman, Django (Seattle, WA); Li, Fu (Bothell, WA); [...]

Published
2019

89. Patent Application Titled 'De-Epoxidized Epothilone Derivative Preparation, Preparation Of Same And Use Thereof In The Treatment Of Tumour' Published Online (USPTO 20190070152)

Subjects
Carboplatin -- Intellectual property, Pertuzumab, Tumors, Lapatinib, Bevacizumab -- Intellectual property, Women's health, Cancer patients, Health, Editors, Health, Women's issues/gender studies
Abstract

2019 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

90. 'Combination Therapy For Treatment Of Ovarian Cancer' in Patent Application Approval Process (USPTO 20190060285)

Subjects
Carboplatin -- Intellectual property, Cancer treatment, Niraparib -- Intellectual property, Ovarian cancer, Rucaparib -- Intellectual property, Olaparib, Women's health, Women, Editors, Health, Women's issues/gender studies
Abstract

2019 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventor Proia, David (Newton, MA), filed on February 28, [...]

Published
2019

91. Patent Issued for Combinational Liposome Compositions For Cancer Therapy (USPTO 10,213,385)

Subjects
Cancer, Carboplatin -- Intellectual property, Physical fitness, Cancer treatment, Drug delivery systems -- Intellectual property, Obesity, Antineoplastic agents, Editors, Health
Abstract

2019 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Mallinckrodt LLC (Hazelwood, Missouri, United States) has been issued patent number 10,213,385, [...]

Published
2019

92. Researchers Submit Patent Application, 'New Use Of Tumor Gene Methylation Regulator And Anti-Tumor Drugs', for Approval (USPTO 20190046470)

Subjects
Cancer, Physical fitness, Carboplatin -- Intellectual property, Methylation, Tumors, Drug approval, Genes, Bevacizumab -- Intellectual property, Antineoplastic agents -- Intellectual property, Obesity, Disclosure of information, Aflibercept, Pemetrexed, Editors, Panitumumab, Cetuximab, Pertuzumab, Drugs, Health
Abstract

2019 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

93. Patent Issued for Dendrogenin A And Antineoplastic Agents For The Treatment Of Chemosensitive Or Chemoresistant Tumors (USPTO 10,188,666)

Subjects
Carboplatin -- Intellectual property, Physical fitness, Vincristine -- Intellectual property, Tumors, Obesity, Antineoplastic agents, Editors, Health
Abstract

2019 FEB 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- INSERM (Institut National de la Sante et de la Recherche Medicale) (Paris, [...]

Published
2019

94. Patent Application Titled 'The Use Of A Temporary Inhibitor Of P53 For Preventing Or Reducing Cancer Relapse' Published Online (USPTO 20190015393)

Subjects
Cancer, Carboplatin -- Intellectual property, Cancer prevention, Tumor proteins, Cancer treatment, Recurrence (Disease), Women's health, Stem cell research, Cancer recurrence, Anopheles, Editors, Health, Women's issues/gender studies
Abstract

2019 FEB 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

95. Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA in combination with a PARP Inhibitor in the United States

Subjects
Carboplatin -- Intellectual property, Cancer -- Care and treatment, DNA damage, Business, international
Abstract

(GlobeNewswire) - Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO) (hereafter Onxeo or the Company), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response [...]

Published
2021

96. Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA in combination with a PARP Inhibitor in the United States

Subjects
Carboplatin -- Intellectual property, Cancer -- Care and treatment, DNA damage, Business, international, Law
Abstract

(GlobeNewswire) - Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO) (hereafter Onxeo or the Company), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response [...]

Published
2021

97. Immutep Limited: IMMUTEP GRANTED CHINESE PATENT FOR EFTILAGIMOD ALPHA IN CHEMO-IMMUNOTHERAPY COMBINATION

Subjects
Carboplatin -- Intellectual property, Immunotherapy, Chemotherapy, Patents, Cancer -- Chemotherapy, Patent/copyright issue, General interest, News, opinion and commentary
Abstract

Sydney, Australia: Immutep Limited has issued the following news release: SYDNEY, AUSTRALIA - 26 May 2021 - Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company [...]

Published
2021

98. Immutep Granted Chinese Patent For Eftilagimod Alpha In Chemo-Immunotherapy Combination

Subjects
Carboplatin -- Intellectual property, Immunotherapy, Chemotherapy, Patents, Cancer -- Chemotherapy, Patent/copyright issue, Business, international, Law
Abstract

(GlobeNewswire) - Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce the grant [...]

Published
2021

99. 'Non-Invasive Urinary Biomarkers For The Detection Of Urothelial Carcinoma Of The Bladder' in Patent Application Approval Process (USPTO 20210355547)

Subjects
Carboplatin -- Intellectual property, Ipilimumab, Immunotherapy, Carcinoma, Cancer, Monoclonal antibodies, Biological markers, Health
Abstract

2021 DEC 8 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent application by the inventors Hoque, Mohammad O. (Towson, MD, US); Oki, Akira (Baltimore, [...]

Published
2021

100. Patent Application Titled 'Macropinocytosis In Cancer' Published Online (USPTO 20210346354)

Subjects
Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Cancer, Antimitotic agents -- Intellectual property, Health, Health care industry
Abstract

2021 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results